A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Clinical trial NCT05257395 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05257395
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2025-12-05
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.